Patent: 10,314,888
✉ Email this page to a colleague
Summary for Patent: 10,314,888
| Title: | Therapeutic and cosmetic uses and applications of calreticulin |
| Abstract: | The invention relates to therapeutic and cosmetic uses of calreticulin including reducing or eliminating wrinkles and/or fine lines, tissue repair and reconstruction, repairing damaged bone and/or cartilage, stimulating regeneration of an epidermal appendage, enhancing phagocytosis of bacteria by phagocytes within a wound, treating a wound in a patient suffering from delayed wound healing, treating a corneal wound, and treating or preventing a surgical adhesion. |
| Inventor(s): | Leslie I. Gold, Marek Michalak |
| Assignee: | New York University NYU |
| Application Number: | US15/004,372 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,314,888
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | ABRYSVO | respiratory syncytial virus vaccine | Injection | 125769 | May 31, 2023 | ⤷ Get Started Free | 2036-01-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,314,888
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011160082 | ⤷ Get Started Free |
| United States of America | 9254310 | ⤷ Get Started Free |
| United States of America | 2021393739 | ⤷ Get Started Free |
| United States of America | 2019343923 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
